Inserm U970, Paris Cardiovascular Research Center, 56, rue Leblanc, 75015 Paris, France.
Curr Opin Pharmacol. 2010 Apr;10(2):197-202. doi: 10.1016/j.coph.2010.02.003. Epub 2010 Mar 5.
Atherosclerosis is a chronic inflammatory disease of the arterial wall where both innate and adaptive immune responses contribute to disease initiation and progression. Initial studies have focused on the role of T helper-1 (Th1) and Th2 responses in atherosclerosis, and more recently evidence has been published supporting a protective role of regulatory T cells in this disease. A third member of the T helper set, IL-17-producing T cells, now called Th17 cells, was recently described as a distinct lineage that play important role in autoimmune diseases. Here, we review the current knowledge on the role of effector and regulatory T cell responses in atherosclerosis and discuss the contribution of the Th17 to this disease.
动脉粥样硬化是动脉壁的一种慢性炎症性疾病,固有免疫和适应性免疫应答都有助于疾病的发生和发展。最初的研究集中在 T 辅助细胞 1(Th1)和 Th2 应答在动脉粥样硬化中的作用,最近有证据表明调节性 T 细胞在这种疾病中具有保护作用。T 辅助细胞的第三个成员,即产生白介素-17(IL-17)的 T 细胞,现在被称为 Th17 细胞,最近被描述为一个在自身免疫性疾病中发挥重要作用的独特谱系。在这里,我们综述了效应 T 细胞和调节性 T 细胞应答在动脉粥样硬化中的作用的现有知识,并讨论了 Th17 细胞对这种疾病的贡献。